Mutagen

Last updated
The international pictogram for chemicals that are sensitising, mutagenic, carcinogenic or toxic to reproduction GHS-pictogram-silhouette.svg
The international pictogram for chemicals that are sensitising, mutagenic, carcinogenic or toxic to reproduction

In genetics, a mutagen is a physical or chemical agent that permanently changes genetic material, usually DNA, in an organism and thus increases the frequency of mutations above the natural background level. As many mutations can cause cancer in animals, such mutagens can therefore be carcinogens, although not all necessarily are. All mutagens have characteristic mutational signatures with some chemicals becoming mutagenic through cellular processes.

Contents

The process of DNA becoming modified is called mutagenesis. Not all mutations are caused by mutagens: so-called "spontaneous mutations" occur due to spontaneous hydrolysis, errors in DNA replication, repair and recombination.

Discovery

The first mutagens to be identified were carcinogens, substances that were shown to be linked to cancer. Tumors were described more than 2,000 years before the discovery of chromosomes and DNA; in 500 B.C., the Greek physician Hippocrates named tumors resembling a crab karkinos (from which the word "cancer" is derived via Latin), meaning crab. [1] In 1567, Swiss physician Paracelsus suggested that an unidentified substance in mined ore (identified as radon gas in modern times) caused a wasting disease in miners, [2] and in England, in 1761, John Hill made the first direct link of cancer to chemical substances by noting that excessive use of snuff may cause nasal cancer. [3] In 1775, Sir Percivall Pott wrote a paper on the high incidence of scrotal cancer in chimney sweeps, and suggested chimney soot as the cause of scrotal cancer. [4] In 1915, Yamagawa and Ichikawa showed that repeated application of coal tar to rabbit's ears produced malignant cancer. [5] Subsequently, in the 1930s the carcinogen component in coal tar was identified as a polyaromatic hydrocarbon (PAH), benzo[a]pyrene. [2] [6] Polyaromatic hydrocarbons are also present in soot, which was suggested to be a causative agent of cancer over 150 years earlier.

The association of exposure to radiation and cancer had been observed as early as 1902, six years after the discovery of X-ray by Wilhelm Röntgen and radioactivity by Henri Becquerel. [7] Georgii Nadson and German Filippov were the first who created fungi mutants under ionizing radiation in 1925. [8] [9] The mutagenic property of mutagens was first demonstrated in 1927, when Hermann Muller discovered that x-rays can cause genetic mutations in fruit flies, producing phenotypic mutants as well as observable changes to the chromosomes, [10] [11] visible due to the presence of enlarged "polytene" chromosomes in fruit fly salivary glands. [12] His collaborator Edgar Altenburg also demonstrated the mutational effect of UV radiation in 1928. [13] Muller went on to use x-rays to create Drosophila mutants that he used in his studies of genetics. [14] He also found that X-rays not only mutate genes in fruit flies, [10] but also have effects on the genetic makeup of humans. [15] [ better source needed ] Similar work by Lewis Stadler also showed the mutational effect of X-rays on barley in 1928, [16] and ultraviolet (UV) radiation on maize in 1936. [17] The effect of sunlight had previously been noted in the nineteenth century where rural outdoor workers and sailors were found to be more prone to skin cancer. [18]

Chemical mutagens were not demonstrated to cause mutation until the 1940s, when Charlotte Auerbach and J. M. Robson found that mustard gas can cause mutations in fruit flies. [19] A large number of chemical mutagens have since been identified, especially after the development of the Ames test in the 1970s by Bruce Ames that screens for mutagens and allows for preliminary identification of carcinogens. [20] [21] Early studies by Ames showed around 90% of known carcinogens can be identified in Ames test as mutagenic (later studies however gave lower figures), [22] [23] [24] and ~80% of the mutagens identified through Ames test may also be carcinogens. [24] [25]

Difference between mutagens and carcinogens

Mutagens are not necessarily carcinogens, and vice versa. Sodium azide for example may be mutagenic (and highly toxic), but it has not been shown to be carcinogenic. [26] Meanwhile, compounds which are not directly mutagenic but stimulate cell growth which can reduce the effectiveness of DNA repair and indirectly increase the chance of mutations, and therefore that of cancer. [27] One example of this would be anabolic steroids, which stimulate growth of the prostate gland and increase the risk of prostate cancer among others. [28] Other carcinogens may cause cancer through a variety of mechanisms without producing mutations, such as tumour promotion, immunosuppression that reduces the ability to fight cancer cells or pathogens that can cause cancer, disruption of the endocrine system (e.g. in breast cancer), tissue-specific toxicity, and inflammation (e.g. in colorectal cancer). [29]

Difference between mutagens and DNA damaging agents

A DNA damaging agent is an agent that causes a change in the structure of DNA that is not itself replicated when the DNA is replicated. [30] Examples of DNA damage include a chemical addition or disruption of a nucleotide base in DNA (generating an abnormal nucleotide or nucleotide fragment), or a break in one or both strands in DNA. When duplex DNA containing a damaged base is replicated, an incorrect base may be inserted in the newly synthesized strand opposite the damaged base in the complementary template strand, and this can become a mutation in the next round of replication. Also a DNA double-strand break may be repaired by an inaccurate process leading to an altered base pair, a mutation. However, mutations and DNA damages differ in a fundamental way: mutations can, in principle, be replicated when DNA replicates, whereas DNA damages are not necessarily replicated. Thus DNA damaging agents often cause mutations as a secondary consequence, but not all DNA damages lead to mutation and not all mutations arise from a DNA damage. [30] The term genotoxic means toxic (damaging) to DNA.

Effects

Mutagens can cause changes to the DNA and are therefore genotoxic. They can affect the transcription and replication of the DNA, which in severe cases can lead to cell death. The mutagen produces mutations in the DNA, and deleterious mutation can result in aberrant, impaired or loss of function for a particular gene, and accumulation of mutations may lead to cancer. Mutagens may therefore be also carcinogens. However, some mutagens exert their mutagenic effect through their metabolites, and therefore whether such mutagens actually become carcinogenic may be dependent on the metabolic processes of an organism, and a compound shown to be mutagenic in one organism may not necessarily be carcinogenic in another. [31]

Different mutagens act on DNA differently. Powerful mutagens may result in chromosomal instability, [32] causing chromosomal breakages and rearrangement of the chromosomes such as translocation, deletion, and inversion. Such mutagens are called clastogens.

Mutagens may also modify the DNA sequence; the changes in nucleic acid sequences by mutations include substitution of nucleotide base-pairs and insertions and deletions of one or more nucleotides in DNA sequences. Although some of these mutations are lethal or cause serious disease, many have minor effects as they do not result in residue changes that have significant effect on the structure and function of the proteins. Many mutations are silent mutations, causing no visible effects at all, either because they occur in non-coding or non-functional sequences, or they do not change the amino-acid sequence due to the redundancy of codons. [33] Some mutagens can cause aneuploidy and change the number of chromosomes in the cell. They are known as aneuploidogens. [34]

In Ames test, where the varying concentrations of the chemical are used in the test, the dose response curve obtained is nearly always linear, suggesting that there may be no threshold for mutagenesis. Similar results are also obtained in studies with radiations, indicating that there may be no safe threshold for mutagens. However, the no-threshold model is disputed with some arguing for a dose rate dependent threshold for mutagenesis. [35] [10] Some have proposed that low level of some mutagens may stimulate the DNA repair processes and therefore may not necessarily be harmful. More recent approaches with sensitive analytical methods have shown that there may be non-linear or bilinear dose-responses for genotoxic effects, and that the activation of DNA repair pathways can prevent the occurrence of mutation arising from a low dose of mutagen. [36]

Types

Mutagens may be of physical, chemical or biological origin. They may act directly on the DNA, causing direct damage to the DNA, and most often result in replication error. Some however may act on the replication mechanism and chromosomal partition. Many mutagens are not mutagenic by themselves, but can form mutagenic metabolites through cellular processes, for example through the activity of the cytochrome P450 system and other oxygenases such as cyclooxygenase. [37] Such mutagens are called promutagens. [38]

Physical mutagens

Chemical mutagens

A DNA adduct (at center) of the mutagenic metabolite of benzo[a]pyrene from tobacco smoke Benzopyrene DNA adduct 1JDG.png
A DNA adduct (at center) of the mutagenic metabolite of benzo[a]pyrene from tobacco smoke

Chemical mutagens either directly or indirectly damage DNA. On this basis, they are of 2 types:

Directly acting chemical mutagens

They directly damage DNA, but may or may not undergo metabolism to produce promutagens (metabolites that can have higher mutagenic potential than their substrates).

  • Reactive oxygen species (ROS) – These may be superoxide, hydroxyl radicals and hydrogen peroxide, and large number of these highly reactive species are generated by normal cellular processes, for example as a by-products of mitochondrial electron transport, or lipid peroxidation. As an example of the latter, 15-hydroperoxyeicosatetraenoic acid, a natural product of cellular cyclooxygenases and lipoxygenases, breaks down to form 4-hydroxy-2(E)-nonenal, 4-hydroperoxy-2(E)-nonenal, 4-oxo-2(E)-nonenal, and cis-4,5-epoxy-2(E)-decanal; these bifunctional electophils are mutagenic in mammalian cells and may contribute to the development and/or progression of human cancers (see 15-Hydroxyicosatetraenoic acid). [39] A number of mutagens may also generate these ROS. These ROS may result in the production of many base adducts, as well as DNA strand breaks and crosslinks.
  • Deaminating agents, for example nitrous acid which can cause transition mutations by converting cytosine to uracil.
  • Polycyclic aromatic hydrocarbons (PAH), when activated to diol-epoxides can bind to DNA and form adducts.
  • Alkylating agents such as ethylnitrosourea. The compounds transfer methyl or ethyl group to bases or the backbone phosphate groups. Guanine when alkylated may be mispaired with thymine. Some may cause DNA crosslinking and breakages. Nitrosamines are an important group of mutagens found in tobacco, and may also be formed in smoked meats and fish via the interaction of amines in food with nitrites added as preservatives. Other alkylating agents include mustard gas and vinyl chloride.
  • Aromatic amines and amides have been associated with carcinogenesis since 1895 when German physician Ludwig Rehn observed high incidence of bladder cancer among workers in German synthetic aromatic amine dye industry. 2-Acetylaminofluorene, originally used as a pesticide but may also be found in cooked meat, may cause cancer of the bladder, liver, ear, intestine, thyroid and breast.
  • Alkaloid from plants, such as those from Vinca species, [40] may be converted by metabolic processes into the active mutagen or carcinogen.
  • Bromine and some compounds that contain bromine in their chemical structure. [41]
  • Sodium azide, an azide salt that is a common reagent in organic synthesis and a component in many car airbag systems
  • Psoralen combined with ultraviolet radiation causes DNA cross-linking and hence chromosome breakage.
  • Benzene, an industrial solvent and precursor in the production of drugs, plastics, synthetic rubber and dyes.
  • Chromium trioxide, a highly toxic and oxidizing substance used in electroplating. [42]

Indirectly acting chemical mutagens

They are not necessarily mutagenic by themselves, but they produce promutagens mutagenic compounds through metabolic processes in cells.

Some chemical mutagens additionally require UV or visible light activation for their mutagenic effect. These are the photomutagens, which include furocoumarins and limettin. [46]

Base analogs

Intercalating agents

Metals

Many metals, such as arsenic, cadmium, chromium, nickel and their compounds may be mutagenic, but they may act, however, via a number of different mechanisms. [47] Arsenic, chromium, iron, and nickel may be associated with the production of ROS, and some of these may also alter the fidelity of DNA replication. Nickel may also be linked to DNA hypermethylation and histone deacetylation, while some metals such as cobalt, arsenic, nickel and cadmium may also affect DNA repair processes such as DNA mismatch repair, and base and nucleotide excision repair. [48]

Biological agents

Protection

Fruits and vegetables are rich in antioxidants. Fruits veggies.png
Fruits and vegetables are rich in antioxidants.

Antioxidants are an important group of anticarcinogenic compounds that may help remove ROS or potentially harmful chemicals. These may be found naturally in fruits and vegetables. [51] Examples of antioxidants are vitamin A and its carotenoid precursors, vitamin C, vitamin E, polyphenols, and various other compounds. β-Carotene is the red-orange colored compounds found in vegetables like carrots and tomatoes. Vitamin C may prevent some cancers by inhibiting the formation of mutagenic N-nitroso compounds (nitrosamine). Flavonoids, such as EGCG in green tea, have also been shown to be effective antioxidants and may have anti-cancer properties. Epidemiological studies indicate that a diet rich in fruits and vegetables is associated with lower incidence of some cancers and longer life expectancy, [52] however, the effectiveness of antioxidant supplements in cancer prevention in general is still the subject of some debate. [52] [53]

Other chemicals may reduce mutagenesis or prevent cancer via other mechanisms, although for some the precise mechanism for their protective property may not be certain. Selenium, which is present as a micronutrient in vegetables, is a component of important antioxidant enzymes such as gluthathione peroxidase. Many phytonutrients may counter the effect of mutagens; for example, sulforaphane in vegetables such as broccoli has been shown to be protective against prostate cancer. [54] Others that may be effective against cancer include indole-3-carbinol from cruciferous vegetables and resveratrol from red wine. [55]

An effective precautionary measure an individual can undertake to protect themselves is by limiting exposure to mutagens such as UV radiations and tobacco smoke. In Australia, where people with pale skin are often exposed to strong sunlight, melanoma is the most common cancer diagnosed in people aged 15–44 years. [56] [57]

In 1981, human epidemiological analysis by Richard Doll and Richard Peto indicated that smoking caused 30% of cancers in the US. [58] Diet is also thought to cause a significant number of cancer, and it has been estimated that around 32% of cancer deaths may be avoidable by modification to the diet. [59] Mutagens identified in food include mycotoxins from food contaminated with fungal growths, such as aflatoxins which may be present in contaminated peanuts and corn; heterocyclic amines generated in meat when cooked at high temperature; PAHs in charred meat and smoked fish, as well as in oils, fats, bread, and cereal; [60] and nitrosamines generated from nitrites used as food preservatives in cured meat such as bacon (ascorbate, which is added to cured meat, however, reduces nitrosamine formation). [51] Overly-browned starchy food such as bread, biscuits and potatoes can generate acrylamide, a chemical shown to cause cancer in animal studies. [61] [62] Excessive alcohol consumption has also been linked to cancer; the possible mechanisms for its carcinogenicity include formation of the possible mutagen acetaldehyde, and the induction of the cytochrome P450 system which is known to produce mutagenic compounds from promutagens. [63]

For certain mutagens, such as dangerous chemicals and radioactive materials, as well as infectious agents known to cause cancer, government legislations and regulatory bodies are necessary for their control. [64]

Test systems

Many different systems for detecting mutagen have been developed. [65] [66] Animal systems may more accurately reflect the metabolism of human, however, they are expensive and time-consuming (may take around three years to complete), they are therefore not used as a first screen for mutagenicity or carcinogenicity.

Bacterial

Yeast

Systems similar to Ames test have been developed in yeast. Saccharomyces cerevisiae is generally used. These systems can check for forward and reverse mutations, as well as recombinant events.

Drosophila

Sex-Linked Recessive Lethal Test – Males from a strain with yellow bodies are used in this test. The gene for the yellow body lies on the X-chromosome. The fruit flies are fed on a diet of test chemical, and progenies are separated by sex. The surviving males are crossed with the females of the same generation, and if no males with yellow bodies are detected in the second generation, it would indicate a lethal mutation on the X-chromosome has occurred.

Plant assays

Plants such as Zea mays , Arabidopsis thaliana and Tradescantia have been used in various test assays for mutagenecity of chemicals.

Cell culture assay

Mammalian cell lines such as Chinese hamster V79 cells, Chinese hamster ovary (CHO) cells or mouse lymphoma cells may be used to test for mutagenesis. Such systems include the HPRT assay for resistance to 8-azaguanine or 6-thioguanine, and ouabain-resistance (OUA) assay.

Rat primary hepatocytes may also be used to measure DNA repair following DNA damage. Mutagens may stimulate unscheduled DNA synthesis that results in more stained nuclear material in cells following exposure to mutagens.

Chromosome check systems

These systems check for large scale changes to the chromosomes and may be used with cell culture or in animal test. The chromosomes are stained and observed for any changes. Sister chromatid exchange is a symmetrical exchange of chromosome material between sister chromatids and may be correlated to the mutagenic or carcinogenic potential of a chemical. In micronucleus Test, cells are examined for micronuclei, which are fragments or chromosomes left behind at anaphase, and is therefore a test for clastogenic agents that cause chromosome breakages. Other tests may check for various chromosomal aberrations such as chromatid and chromosomal gaps and deletions, translocations, and ploidy.

Animal test systems

Rodents are usually used in animal test. The chemicals under test are usually administered in the food and in the drinking water, but sometimes by dermal application, by gavage, or by inhalation, and carried out over the major part of the life span for rodents. In tests that check for carcinogens, maximum tolerated dosage is first determined, then a range of doses are given to around 50 animals throughout the notional lifespan of the animal of two years. After death the animals are examined for sign of tumours. Differences in metabolism between rat and human however means that human may not respond in exactly the same way to mutagen, and dosages that produce tumours on the animal test may also be unreasonably high for a human, i.e. the equivalent amount required to produce tumours in human may far exceed what a person might encounter in real life.

Mice with recessive mutations for a visible phenotype may also be used to check for mutagens. Females with recessive mutation crossed with wild-type males would yield the same phenotype as the wild-type, and any observable change to the phenotype would indicate that a mutation induced by the mutagen has occurred.

Mice may also be used for dominant lethal assays where early embryonic deaths are monitored. Male mice are treated with chemicals under test, mated with females, and the females are then sacrificed before parturition and early fetal deaths are counted in the uterine horns.

Transgenic mouse assay using a mouse strain infected with a viral shuttle vector is another method for testing mutagens. Animals are first treated with suspected mutagen, the mouse DNA is then isolated and the phage segment recovered and used to infect E. coli. Using similar method as the blue-white screen, the plaque formed with DNA containing mutation are white, while those without are blue.

In anti-cancer therapy

Many mutagens are highly toxic to proliferating cells, and they are often used to destroy cancer cells. Alkylating agents such as cyclophosphamide and cisplatin, as well as intercalating agent such as daunorubicin and doxorubicin may be used in chemotherapy. However, due to their effect on other cells which are also rapidly dividing, they may have side effects such as hair loss and nausea. Research on better targeted therapies may reduce such side-effects. Ionizing radiations are used in radiation therapy.

In fiction

In science fiction, mutagens are often represented as substances that are capable of completely changing the form of the recipient or granting them superpowers. Powerful radiations are the agents of mutation for the superheroes in Marvel Comics's Fantastic Four, Daredevil, and Hulk, while in the Ninja Turtles franchise the MUTAGEN "ooze" for Inhumans the mutagen is the Terrigen Mist. Mutagens are also featured in video games such as Cyberia, System Shock, The Witcher , Metroid Prime: Trilogy , Resistance: Fall of Man , Resident Evil , Infamous , Freedom Force, Command & Conquer , Gears of War 3 , StarCraft , BioShock , Fallout , Underrail , and Maneater . In the "nuclear monster" films of the 1950s, nuclear radiation mutates humans and common insects often to enormous size and aggression; these films include Godzilla , Them! , Attack of the 50 Foot Woman , Tarantula! , and The Amazing Colossal Man .

See also

Related Research Articles

<span class="mw-page-title-main">Ames test</span> Biological testing method

The Ames test is a widely employed method that uses bacteria to test whether a given chemical can cause mutations in the DNA of the test organism. More formally, it is a biological assay to assess the mutagenic potential of chemical compounds. A positive test indicates that the chemical is mutagenic and therefore may act as a carcinogen, because cancer is often linked to mutation. The test serves as a quick and convenient assay to estimate the carcinogenic potential of a compound because standard carcinogen assays on mice and rats are time-consuming and expensive. However, false-positives and false-negatives are known.

<span class="mw-page-title-main">Carcinogen</span> Substance, radionuclide, or radiation directly involved in causing cancer

A carcinogen is any agent that promotes the development of cancer. Carcinogens can include synthetic chemicals, naturally occurring substances, physical agents such as ionizing and non-ionizing radiation, and biologic agents such as viruses and bacteria. Most carcinogens act by creating mutations in DNA that disrupt a cell's normal processes for regulating growth, leading to uncontrolled cellular proliferation. This occurs when the cell's DNA repair processes fail to identify DNA damage allowing the defect to be passed down to daughter cells. The damage accumulates over time. This is typically a multi-step process during which the regulatory mechanisms within the cell are gradually dismantled allowing for unchecked cellular division.

Mutagenesis is a process by which the genetic information of an organism is changed by the production of a mutation. It may occur spontaneously in nature, or as a result of exposure to mutagens. It can also be achieved experimentally using laboratory procedures. A mutagen is a mutation-causing agent, be it chemical or physical, which results in an increased rate of mutations in an organism's genetic code. In nature mutagenesis can lead to cancer and various heritable diseases, and it is also a driving force of evolution. Mutagenesis as a science was developed based on work done by Hermann Muller, Charlotte Auerbach and J. M. Robson in the first half of the 20th century.

<span class="mw-page-title-main">Mutation</span> Alteration in the nucleotide sequence of a genome

In biology, a mutation is an alteration in the nucleic acid sequence of the genome of an organism, virus, or extrachromosomal DNA. Viral genomes contain either DNA or RNA. Mutations result from errors during DNA or viral replication, mitosis, or meiosis or other types of damage to DNA, which then may undergo error-prone repair, cause an error during other forms of repair, or cause an error during replication. Mutations may also result from insertion or deletion of segments of DNA due to mobile genetic elements.

<span class="mw-page-title-main">SOS response</span> Cell response to DNA damage

The SOS response is a global response to DNA damage in which the cell cycle is arrested and DNA repair and mutagenesis are induced. The system involves the RecA protein. The RecA protein, stimulated by single-stranded DNA, is involved in the inactivation of the repressor (LexA) of SOS response genes thereby inducing the response. It is an error-prone repair system that contributes significantly to DNA changes observed in a wide range of species.

Genotoxicity is the property of chemical agents that damage the genetic information within a cell causing mutations, which may lead to cancer. While genotoxicity is often confused with mutagenicity, all mutagens are genotoxic, but some genotoxic substances are not mutagenic. The alteration can have direct or indirect effects on the DNA: the induction of mutations, mistimed event activation, and direct DNA damage leading to mutations. The permanent, heritable changes can affect either somatic cells of the organism or germ cells to be passed on to future generations. Cells prevent expression of the genotoxic mutation by either DNA repair or apoptosis; however, the damage may not always be fixed leading to mutagenesis.

<span class="mw-page-title-main">Auxotrophy</span> Inability to synthesize an organic compound required for growth

Auxotrophy is the inability of an organism to synthesize a particular organic compound required for its growth. An auxotroph is an organism that displays this characteristic; auxotrophic is the corresponding adjective. Auxotrophy is the opposite of prototrophy, which is characterized by the ability to synthesize all the compounds needed for growth.

<span class="mw-page-title-main">Bruce Ames</span> American biochemist (born 1928)

Bruce Nathan Ames is an American biochemist who is a professor of biochemistry and Molecular Biology Emeritus at the University of California, Berkeley, and was a senior scientist at Children's Hospital Oakland Research Institute (CHORI). Ames has made contributions to understanding the mechanisms of mutagenesis and DNA repair. He invented the Ames test, a widely used assay for easily and cheaply evaluating the mutagenicity of compounds. The test revolutionized the field of toxicology and has played a crucial role in identifying numerous environmental and industrial carcinogens.

<span class="mw-page-title-main">Molecular lesion</span> Damage to the structure of a biological molecule

A molecular lesion or point lesion is damage to the structure of a biological molecule such as DNA, RNA, or protein. This damage may result in the reduction or absence of normal function, and in rare cases the gain of a new function. Lesions in DNA may consist of breaks or other changes in chemical structure of the helix, ultimately preventing transcription. Meanwhile, lesions in proteins consist of both broken bonds and improper folding of the amino acid chain. While many nucleic acid lesions are general across DNA and RNA, some are specific to one, such as thymine dimers being found exclusively in DNA. Several cellular repair mechanisms exist, ranging from global to specific, in order to prevent lasting damage resulting from lesions.

<span class="mw-page-title-main">Clastogen</span> Substance that can cause breaks in chromosomes

A clastogen is a mutagenic agent that disturbs normal DNA related processes or directly causes DNA strand breakages, thus causing the deletion, insertion, or rearrangement of entire chromosome sections. These processes are a form of mutagenesis which if left unrepaired, or improperly repaired, can lead to cancer. Known clastogens include acridine yellow, benzene, ethylene oxide, arsenic, phosphine, mimosine, actinomycin D, camptothecin, methotrexate, methyl acrylate, resorcinol and 5-fluorodeoxyuridine. Additionally, 1,2-dimethylhydrazine is a known colon carcinogen and shows signs of possessing clastogenic activity. There are many clastogens not listed here and research is ongoing to discover new clastogens. Some known clastogens only exhibit clastogenic activity in certain cell types, such as caffeine which exhibits clastogenic activity in plant cells. Researchers are interested in clastogens for researching cancer, as well as for other human health concerns such as the inheritability of clastogen effected paternal germ cells that lead to fetus developmental defects.

<span class="mw-page-title-main">Crosslinking of DNA</span> Phenomenon in genetics

In genetics, crosslinking of DNA occurs when various exogenous or endogenous agents react with two nucleotides of DNA, forming a covalent linkage between them. This crosslink can occur within the same strand (intrastrand) or between opposite strands of double-stranded DNA (interstrand). These adducts interfere with cellular metabolism, such as DNA replication and transcription, triggering cell death. These crosslinks can, however, be repaired through excision or recombination pathways.

<span class="mw-page-title-main">Methylnitronitrosoguanidine</span> Chemical compound

Methylnitronitrosoguanidine (MNNG or MNG, NTG when referred to colloquially as nitrosoguanidine) is a biochemical tool used experimentally as a carcinogen and mutagen. It acts by adding alkyl groups to the O6 of guanine and O4 of thymine, which can lead to transition mutations between GC and AT. These changes do not cause a heavy distortion in the double helix of DNA and thus are hard to detect by the DNA mismatch repair system.

The Environmental Mutagenesis and Genomics Society (EMGS) is a scientific society "for the promotion of critical scientific knowledge and research into the causes and consequences of damage to the genome and epigenome in order to inform and support national and international efforts to ensure a healthy, sustainable environment for future generations."

<span class="mw-page-title-main">SOS chromotest</span>

The SOS chromotest is a biological assay to assess the genotoxic potential of chemical compounds. The test is a colorimetric assay which measures the expression of genes induced by genotoxic agents in Escherichia coli, by means of a fusion with the structural gene for β-galactosidase. The test is performed over a few hours in columns of a 96-well microplate with increasing concentrations of test samples. This test was developed as a practical complement or alternative to the traditional Ames test assay for genotoxicity, which involves growing bacteria on agar plates and comparing natural mutation rates to mutation rates of bacteria exposed to potentially mutagenic compounds or samples. The SOS chromotest is comparable in accuracy and sensitivity to established methods such as the Ames test and is a useful tool to screen genotoxic compounds, which could prove carcinogenic in humans, in order to single out chemicals for further in-depth analysis.

For pharmacology and genetics, the Umu Chromotest, first developed and published by Oda et al., is a biological assay (bioassay) to assess the genotoxic potential of chemical compounds. It is based on the ability of DNA-damaging agents to induce the expression of the umu operon. In connection with the damage inducible (din) genes recA, lexA and umuD, the umuC gene is essentially involved in bacterial mutagenesis through the SOS response.

<span class="mw-page-title-main">2-Aminofluorene</span> Chemical compound

2-Aminofluorene (2-AF) is a synthetic arylamine. It is a white to tan solid with a melting point of 125-132 °C. 2-AF has only been tested in controlled laboratory settings thus far. There is no indication that it will be tested in industrialized settings. There is evidence that 2-aminofluorene is a carcinogen and an intercalating agent that is extremely dangerous to genomic DNA that potentially can lead to mutation if not death. Furthermore, it has been suggested that 2-aminofluorene can undergo acetylation reactions that causes these reactive species to undergo such reactions in cells. Several experiments have been conducted that have suggested 2-aminofluorene be treated with care and with an overall awareness of the toxicity of this compound.

Antimutagens are the agents that interfere with the mutagenicity of a substance. The interference can be in the form of prevention of the transformation of a promutagenic compound into actual active mutagen, inactivation, or otherwise the prevention of Mutagen-DNA reaction.

Benzo(<i>c</i>)fluorene Chemical compound

Benzo[c]fluorene is a polycyclic aromatic hydrocarbon (PAH) with mutagenic activity. It is a component of coal tar, cigarette smoke and smog and thought to be a major contributor to its carcinogenic properties. The mutagenicity of benzo[c]fluorene is mainly attributed to formation of metabolites that are reactive and capable of forming DNA adducts. According to the KEGG it is a group 3 carcinogen. Other names for benzo[c]fluorene are 7H-benzo[c]fluorene, 3,4-benzofluorene, and NSC 89264.

Mutational signatures are characteristic combinations of mutation types arising from specific mutagenesis processes such as DNA replication infidelity, exogenous and endogenous genotoxin exposures, defective DNA repair pathways, and DNA enzymatic editing.

Sheldon Wolff was an American radiobiologist, cytogeneticist, and environmental health expert on mutagenic chemicals.

References

  1. Papavramidou N, Papavramidis T, Demetriou T (March 2010). "Ancient Greek and Greco-Roman methods in modern surgical treatment of cancer". Annals of Surgical Oncology. 17 (3): 665–7. doi:10.1245/s10434-009-0886-6. PMC   2820670 . PMID   20049643.
  2. 1 2 Luch, A. "Nature and Nurture - Lessons from Chemical Carcinogenesis: Chemical Carcinogens — From Past to Present" . www.medscape.com. Archived from the original on 19 March 2011.
  3. Hill J (1761). Cautions against the immoderate use of snuff: founded on the known qualities of the tobacco plant: and the effects it must produce when this way taken into the body: and enforced by instances of persons who have perished miserably of diseases, occasioned, or rendered incurable by its use. London: Printed for Baldwin R and Jackson J.
  4. Brown JR, Thornton JL (January 1957). "Percivall Pott (1714-1788) and chimney sweepers' cancer of the scrotum". British Journal of Industrial Medicine. 14 (1): 68–70. doi:10.1136/oem.14.1.68. PMC   1037746 . PMID   13396156.
  5. Yamagawa K, Ichikawa K (1915). "Experimentelle Studie über die Pathogenese der Epithelialgeschwülste". Mitteilungen aus der Medizinischen Fakultät der Kaiserlichen Universität zu Tokyo. 15: 295–344. doi:10.11501/1675887.
  6. Cook JW, Hewett CL, Hieger I (1933). "The isolation of a cancer-producing hydrocarbon from coal tar". J. Chem. Soc. 24: 395–405. doi:10.1039/JR9330000395.
  7. Kathren RL (Dec 2002). "Historical Development of the Linear Nonthreshold Dose-Response Model as Applied to Radiation". University of New Hampshire Law Review. 1 (1).
  8. ""Russian Trail" in the Discovery of DNA Structure". SCIENCE First Hand. Vol. 3, no. N2. INFOLIO. 2004. Archived from the original on 18 August 2017.
  9. Böhme H (1961). "Angewandte Mikrobiologie". In Bünning E, Gäumann E (eds.). Bericht über das Jahr 1960 (in German). Vol. 23. Berlin: Springer Verlag. pp. 502–509. doi:10.1007/978-3-642-94810-7_40. ISBN   978-3-642-94811-4. Bereits kurz nach der Entdeckung der Möglichkeit einer Auslösung von Mutationen durch ionisierende Strahlen (Nadson u. Filippov 1925, 1928; Muller 1927)
  10. 1 2 3 Calabrese EJ (December 2011). "Muller's Nobel lecture on dose-response for ionizing radiation: ideology or science?" (PDF). Archives of Toxicology. 85 (12): 1495–8. doi:10.1007/s00204-011-0728-8. PMID   21717110. S2CID   4708210. Archived (PDF) from the original on 2 August 2017.
  11. Muller HJ (July 1927). "Artificial Transmutation of the Gene" (PDF). Science. 66 (1699): 84–7. Bibcode:1927Sci....66...84M. doi:10.1126/science.66.1699.84. PMID   17802387. Archived (PDF) from the original on 30 October 2012.
  12. Griffiths AJ, Wessler SR, Carroll SB, Doebley J (2012). Introduction to Genetic Analysis (10th ed.). W. H. Freeman. p. 255. ISBN   978-1-4292-7634-4.
  13. Altenburg E (1928). "The Limit of Radiation Frequency Effective in Producing Mutations". Am. Nat. 62 (683): 540–545. doi:10.1086/280230. JSTOR   2457052. S2CID   83653780.
  14. Crow JF, Abrahamson S (December 1997). "Seventy years ago: mutation becomes experimental". Genetics. 147 (4): 1491–6. doi:10.1093/genetics/147.4.1491. PMC   1208325 . PMID   9409815.
  15. Campbell NA, Reece JB (2005). Biology (7th ed.). San Francisco, CA: Pearson Education, Inc. ISBN   978-0-8053-7146-8.
  16. Stadler LJ (August 1928). "Mutations in Barley Induced by X-Rays and Radium". Science. 68 (1756): 186–7. Bibcode:1928Sci....68..186S. doi:10.1126/science.68.1756.186. PMID   17774921.
  17. Stadler LJ, Sprague GF (October 1936). "Genetic Effects of Ultra-Violet Radiation in Maize: I. Unfiltered Radiation". Proceedings of the National Academy of Sciences of the United States of America. 22 (10): 572–8. Bibcode:1936PNAS...22..572S. doi: 10.1073/pnas.22.10.572 . PMC   1076819 . PMID   16588111.
  18. Hockberger PE (December 2002). "A history of ultraviolet photobiology for humans, animals and microorganisms". Photochemistry and Photobiology. 76 (6): 561–79. doi:10.1562/0031-8655(2002)0760561AHOUPF2.0.CO2. PMID   12511035. S2CID   222100404. Archived from the original on 17 November 2011.
  19. Auerbach C, Robson JM, Carr JG (March 1947). "The Chemical Production of Mutations". Science. 105 (2723): 243–7. Bibcode:1947Sci...105..243A. doi:10.1126/science.105.2723.243. PMID   17769478.
  20. Ames BN, Lee FD, Durston WE (March 1973). "An improved bacterial test system for the detection and classification of mutagens and carcinogens". Proceedings of the National Academy of Sciences of the United States of America. 70 (3): 782–6. Bibcode:1973PNAS...70..782A. doi: 10.1073/pnas.70.3.782 . PMC   433358 . PMID   4577135.
  21. Ames BN (May 1979). "Identifying environmental chemicals causing mutations and cancer". Science. 204 (4393): 587–93. Bibcode:1979Sci...204..587A. doi:10.1126/science.373122. JSTOR   1748159. PMID   373122.
  22. McCann J, Choi E, Yamasaki E, et al. (December 1975). "Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals". Proceedings of the National Academy of Sciences of the United States of America. 72 (12): 5135–9. Bibcode:1975PNAS...72.5135M. doi: 10.1073/pnas.72.12.5135 . PMC   388891 . PMID   1061098.
  23. McCann J, Gold LS, Horn L, et al. (1988). "Statistical analysis of Salmonella test data and comparison to results of animal cancer tests" (PDF). Mutation Research. 205 (1–4): 183–95. doi:10.1016/0165-1218(88)90017-1. PMID   3285186. Archived from the original (PDF) on 30 October 2012.
  24. 1 2 Dunkel VC, Zeiger E, Brusick D, et al. (1985). "Reproducibility of microbial mutagenicity assays: II. Testing of carcinogens and noncarcinogens in Salmonella typhimurium and Escherichia coli". Environmental Mutagenesis. 7 Suppl 5 (suppl. 5): 1–248. doi:10.1002/em.2860070902. PMID   3905369.
  25. Benigni R, Bossa C (May 2011). "Alternative strategies for carcinogenicity assessment: an efficient and simplified approach based on in vitro mutagenicity and cell transformation assays". Mutagenesis. 26 (3): 455–60. doi: 10.1093/mutage/ger004 . PMID   21398403.
  26. "Toxicology And Carcinogenesis Studies Of Sodium Azide in F344/N Rats" (PDF). nih.gov (technical report). NIH. 1991. Archived (PDF) from the original on 23 October 2011.
  27. Hill, John; McCreary, John (2019). "22.6 Carcinogens and Teratogens". Chemistry for Changing Times (15 ed.). Pearson. doi:10.1021/ed050pa44.2. ISBN   978-0-13-498863-4.
  28. Salerno, Monica; Cascio, Orazio; Bertozzi, Giuseppe; Sessa, Francesco; Messina, Antonietta; Monda, Vincenzo; Cipolloni, Luigi; Biondi, Antonio; Daniele, Aurora; Pomara, Cristoforo (2018-04-10). "Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review". Oncotarget. 9 (27): 19415–19426. doi:10.18632/oncotarget.24767. ISSN   1949-2553. PMC   5922407 . PMID   29721213.
  29. Lya G. Hernández; Harry van Steeg; Mirjam Luijten; Jan van Benthem (2009). "Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach". Mutation Research/Reviews in Mutation Research. 682 (2–3): 94–109. doi:10.1016/j.mrrev.2009.07.002. PMID   19631282.
  30. 1 2 Bernstein, C.; Bernstein, H. (1991). Aging, Sex, and DNA Repair. pgs. 15-16. San Diego: Academic Press. ISBN   978-0-12-092860-6
  31. Allen JW, DeWeese GK, Gibson JB, et al. (January 1987). "Synaptonemal complex damage as a measure of chemical mutagen effects on mammalian germ cells". Mutation Research. 190 (1): 19–24. doi:10.1016/0165-7992(87)90076-5. PMID   3099192.
  32. Huang L, Snyder AR, Morgan WF (September 2003). "Radiation-induced genomic instability and its implications for radiation carcinogenesis". Oncogene. 22 (37): 5848–54. doi: 10.1038/sj.onc.1206697 . PMID   12947391.
  33. Durland, Justin; Ahmadian-Moghadam, Hamid (19 September 2022). "Genetics, Mutagenesis". StatPearls. 2023 Jan. Retrieved 18 November 2023.
  34. Duesberg P, Rasnick D (October 2000). "Aneuploidy, the somatic mutation that makes cancer a species of its own". Cell Motility and the Cytoskeleton. 47 (2): 81–107. doi:10.1002/1097-0169(200010)47:2<81::AID-CM1>3.0.CO;2-#. PMID   11013390.
  35. "Calabrese says mistake led to adopting the LNT model in toxicology". phys.org. 2017. Archived from the original on 1 August 2017. Retrieved 24 Jan 2019. Calabrese says mistake led to adopting the LNT model in toxicology.{{cite web}}: CS1 maint: postscript (link)
  36. Klapacz J, Pottenger LH, Engelward BP, et al. (2016). "Contributions of DNA repair and damage response pathways to the non-linear genotoxic responses of alkylating agents". Mutation Research/Reviews in Mutation Research. 767: 77–91. doi:10.1016/j.mrrev.2015.11.001. PMC   4818947 . PMID   27036068.
  37. Kim D, Guengerich FP (2005). "Cytochrome P450 activation of arylamines and heterocyclic amines". Annual Review of Pharmacology and Toxicology. 45: 27–49. doi:10.1146/annurev.pharmtox.45.120403.100010. PMID   15822170.
  38. "Promutagen - an overview | ScienceDirect Topics".
  39. Lee SH, Williams MV, Dubois RN, et al. (August 2005). "Cyclooxygenase-2-mediated DNA damage". The Journal of Biological Chemistry. 280 (31): 28337–46. doi: 10.1074/jbc.M504178200 . PMID   15964853.
  40. Lipp HP, Hartmann JT, Stanley A (2005). "45 - Cytostatic drugs". In Aronson JK (ed.). Side Effects of Drugs Annual. Vol. 28. Elsevier. pp. 538–551. doi:10.1016/S0378-6080(05)80467-2. ISBN   978-0-444-51571-1. ISSN   0378-6080.{{cite book}}: |journal= ignored (help)
  41. Henderson JP, Byun J, Williams MV, et al. (March 2001). "Production of brominating intermediates by myeloperoxidase. A transhalogenation pathway for generating mutagenic nucleobases during inflammation". The Journal of Biological Chemistry. 276 (11): 7867–75. doi: 10.1074/jbc.M005379200 . PMID   11096071.
  42. Mamyrbaev, Arstan Abdramanovich; Dzharkenov, Timur Agataevich; Imangazina, Zina Amangalievna; Satybaldieva, Umit Abulkhairovna (2015-04-16). "Mutagenic and carcinogenic actions of chromium and its compounds". Environmental Health and Preventive Medicine. 20 (3). Springer Science and Business Media LLC: 159–167. doi:10.1007/s12199-015-0458-2. ISSN   1342-078X. PMC   4434237 . PMID   25877777.
  43. Yu, Hongtao (November 2002). "Environmental carcinogenic polycyclic aromatic hydrocarbons: photochemistry and phototoxicity". Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews. 20 (2): 149–183. doi:10.1081/GNC-120016203. ISSN   1059-0501. PMC   3812823 . PMID   12515673.
  44. Cooke, M.; Dennis, A. J. (1986-01-01). Polynuclear aromatic hydrocarbons: Chemistry, characterization and carcinogenesis. OSTI   7252502.
  45. Nishikawa, Takuro; Miyahara, Emiko; Horiuchi, Masahisa; Izumo, Kimiko; Okamoto, Yasuhiro; Kawai, Yoshichika; Kawano, Yoshifumi; Takeuchi, Toru (January 2012). "Benzene metabolite 1,2,4-benzenetriol induces halogenated DNA and tyrosines representing halogenative stress in the HL-60 human myeloid cell line". Environmental Health Perspectives. 120 (1): 62–67. doi:10.1289/ehp.1103437. ISSN   1552-9924. PMC   3261936 . PMID   21859636.
  46. Raquet, N; Schrenk, D (September 2009). "Relative photomutagenicity of furocoumarins and limettin in the hypoxanthine phosphoribosyl transferase assay in V79 cells". Chemical Research in Toxicology. 22 (9): 1639–47. doi:10.1021/tx9002287. PMID   19725558.
  47. Valko M, Morris H, Cronin MT (2005). "Metals, toxicity and oxidative stress" (PDF). Current Medicinal Chemistry. 12 (10): 1161–208. CiteSeerX   10.1.1.498.2796 . doi:10.2174/0929867053764635. PMID   15892631. Archived (PDF) from the original on 24 August 2015.
  48. "Health Risk Assessment Guidance for Metals – Mutagenicity" (PDF). EBRC. 2007. Archived from the original (PDF) on 12 April 2012.
  49. Ellermann V.; Bang O. (1908). "Experimentelle Leukämie bei Hühnern". Zentralbl. Bakteriol. Parasitenkd. Infectionskr. Hyg. Abt. Orig. 46: 595–609.
  50. Rous P (April 1911). "A Sarcoma of the Fowl Transmissible by an Agent Separable from the Tumor Cells". The Journal of Experimental Medicine. 13 (4): 397–411. doi:10.1084/jem.13.4.397. PMC   2124874 . PMID   19867421.
  51. 1 2 National Research Council, U.S. (1996). Carcinogens and Anticarcinogens in the Human Diet. Washington, D.C: National Academy Press. ISBN   978-0-309-05391-4.
  52. 1 2 Dolara P, Bigagli E, Collins A (October 2012). "Antioxidant vitamins and mineral supplementation, life span expansion and cancer incidence: a critical commentary". European Journal of Nutrition. 51 (7): 769–81. doi:10.1007/s00394-012-0389-2. PMID   22684632. S2CID   36973911.
  53. Li K, Kaaks R, Linseisen J, et al. (June 2012). "Vitamin/mineral supplementation and cancer, cardiovascular, and all-cause mortality in a German prospective cohort (EPIC-Heidelberg)" (PDF). European Journal of Nutrition. 51 (4): 407–13. doi:10.1007/s00394-011-0224-1. PMID   21779961. S2CID   1692747.
  54. Gibbs A, Schwartzman J, Deng V, et al. (September 2009). "Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6". Proceedings of the National Academy of Sciences of the United States of America. 106 (39): 16663–8. Bibcode:2009PNAS..10616663G. doi: 10.1073/pnas.0908908106 . PMC   2757849 . PMID   19805354.
  55. Gullett NP, Ruhul Amin AR, Bayraktar S, et al. (June 2010). "Cancer prevention with natural compounds". Seminars in Oncology. 37 (3): 258–81. doi:10.1053/j.seminoncol.2010.06.014. PMID   20709209.
  56. "Skin Cancer Facts and Figures". Cancer Council. Archived from the original on 10 August 2012. Retrieved 2 Jul 2010.
  57. Callaway, E (2008). "Skin-tone gene could predict cancer risk". New Scientist. Archived from the original on 24 April 2015. Retrieved 24 Jan 2019.
  58. Doll R, Peto R (June 1981). "The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today". Journal of the National Cancer Institute. 66 (6): 1191–308. doi:10.1093/jnci/66.6.1192. PMID   7017215.
  59. Willett WC (November 1995). "Diet, nutrition, and avoidable cancer". Environmental Health Perspectives. 103 (Suppl 8): 165–70. doi:10.1289/ehp.95103s8165. PMC   1518978 . PMID   8741778.
  60. Scientific Committee on Food (4 Dec 2002). "Polycyclic Aromatic Hydrocarbons – Occurrence in foods, dietary exposure and health effects" (PDF). European Commission. Archived from the original (PDF) on 19 May 2011. Retrieved 21 Aug 2010.
  61. Siddique, Haroon (23 Jan 2017). "Roast potatoes and toast that's a bit too brown may cause cancer, say authorities". The Guardian . Archived from the original on 23 January 2017.
  62. Tareke E, Rydberg P, Karlsson P, Eriksson S, Törnqvist M (August 2002). "Analysis of acrylamide, a carcinogen formed in heated foodstuffs". Journal of Agricultural and Food Chemistry. 50 (17): 4998–5006. doi:10.1021/jf020302f. PMID   12166997.
  63. Pöschl G, Seitz HK (2004). "Alcohol and cancer" (PDF). Alcohol and Alcoholism. 39 (3): 155–65. doi:10.1093/alcalc/agh057. PMID   15082451.
  64. Milunsky A, Annas GJ (1980). Genetics and the Law II. Boston, MA: Springer US. ISBN   978-1-4613-3080-6.
  65. Hodgson E (2004). "Chapter 21". A Textbook of Modern Toxicology (3rd ed.). John Wiley & Sons. ISBN   978-0-471-26508-5.
  66. Williams PL, James RC, Roberts SM (2000). Principles of Toxicology – Environmental and Industrial Applications (2nd ed.). John Wiley & Sons. ISBN   978-0-471-29321-7.